Skip to content

News releases

The following are news releases and statements issued by Biosimilars Canada. News stories about biosimilars that may be of interest to readers are available here.

Biosimilars Canada Announces Board Chair and Vice-Chair

Biosimilars Canada is pleased to announce the unanimous re-election of Mr. Michel Robidoux, President and General Manager of Sandoz Canada, as Chair of the Biosimilars Canada Board. Mr. Mike Woolcock, a Senior Vice President at Apobiologix, has been unanimously re-elected as Vice-Chair of the Biosimilars Canada Board.
Read more

CGPA / Biosimilars Canada Statement: COVID-19 and the Supply of Generic and Biosimilar Prescription Medicines to Canada’s Hospitals

Member companies of the Canadian Generic Pharmaceutical Association (CGPA) and Biosimilars Canada are working with our partners in government and the pharmaceutical supply chain to mitigate shortages of medicines used in Canada’s hospitals due to increases in demand resulting from the COVID-19 outbreak.
Read more

CGPA / Biosimilars Canada Statement on COVID-19 and the Supply and Distribution of Generic and Biosimilar Prescription Medicines in Canada

The Canadian Generic Pharmaceutical Association (CGPA) and Biosimilars Canada continue to work closely with Health Canada, member companies and key stakeholders in the pharmaceutical supply chain to help ensure that Canadian patients continue to have access to high-quality generic and biosimilar medicines.
Read more

CGPA / Biosimilars Canada Statement on COVID-19 and the Supply and Distribution of Generic and Biosimilar Prescription Medicines in Canada

The Canadian Generic Pharmaceutical Association (CGPA) and Biosimilars Canada continue to work closely with Health Canada, member companies and key stakeholders in the pharmaceutical supply chain to help ensure that Canadian patients continue to have access to high-quality generic and biosimilar medicines. To date, we are not aware of any drug shortages in Canada related to COVID-19.
Read more

Alberta Becomes Second Province to Implement Biosimilar Switching Initiative

Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, today congratulated the Government of Alberta for becoming the second province in Canada to implement a biosimilar “switching” or transitioning program.
Read more

BC PharmaCare Expands Biosimilar Switching Program

Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, today congratulated the Government of British Columbia for building on the success of its biosimilar switching program and called on other provinces to implement similar programs.
Read more